Literature DB >> 33981793

Dream Enactment Behavior Disorder Associated with Pallido-Nigro-Luysian Degeneration and Tau Proteinopathy.

Daniel G Di Luca1, Elizabeth J Slow1, Ivan Martinez-Valbuena2, Anthony E Lang1, Gabor G Kovacs1,2,3,4.   

Abstract

BACKGROUND: Pallido-nigro-luysian atrophy (PNLA) is a rare neurodegenerative disorder with only a few cases reported to date. Although the clinical picture usually resembles progressive supranuclear palsy, pathological examination reveals more selective atrophy and loss of neurons in the globus pallidus, substantia nigra and subthalamic nucleus.
OBJECTIVES: To describe the clinical features and pathological findings of a patient with PNLA.
METHODS: Case report with clinico-pathological discussion.
RESULTS: An 83-year-old man presented to our clinic with a vertical supranuclear gaze palsy, parkinsonism, gait impairment and sleep abnormalities suggestive of REM-sleep behavior disorder. Neuropathological examination 5 years after symptom onset revealed subcortical tau proteinopathy compatible with a PNLA pattern. There was also an associated mild degree of limbic/subcortical inflammatory response, Alzheimer's disease-related changes, as well as argyrophilic grain disease.
CONCLUSIONS: We present a comprehensive clinico-pathological discussion of a patient with PNLA. Besides parkinsonism and vertical supranuclear gaze palsy, the patient also had a sleep disorder, clinically suggestive of REM behavioral disorder, which has not been previously reported in PNLA. We expand the clinical phenotype of this rare condition and provide neuropathological evidence for the associated abnormalities.
© 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  REM‐sleep behavior disorder; neurodegeneration; pallido‐nigro‐luysian atrophy; progressive supranuclear palsy; tau

Year:  2021        PMID: 33981793      PMCID: PMC8088089          DOI: 10.1002/mdc3.13194

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  20 in total

1.  Staging of argyrophilic grains: an age-associated tauopathy.

Authors:  Yuko Saito; Nyoka N Ruberu; Motoji Sawabe; Tomio Arai; Noriko Tanaka; Yukio Kakuta; Hiroshi Yamanouchi; Shigeo Murayama
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

Review 2.  Secondary ''incidental'' REM sleep behavior disorder: do we ever think of it?

Authors:  Raffaele Manni; Pietro-Luca Ratti; Michele Terzaghi
Journal:  Sleep Med       Date:  2011-12       Impact factor: 3.492

3.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Authors:  Thomas J Montine; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; John Q Trojanowski; Harry V Vinters; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2011-11-20       Impact factor: 17.088

Review 4.  Facial bradykinesia.

Authors:  Matteo Bologna; Giovanni Fabbrini; Luca Marsili; Giovanni Defazio; Philip D Thompson; Alfredo Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-12       Impact factor: 10.154

5.  Copathology in Progressive Supranuclear Palsy: Does It Matter?

Authors:  Milica Jecmenica Lukic; Carolin Kurz; Gesine Respondek; Oriol Grau-Rivera; Yaroslau Compta; Ellen Gelpi; Claire Troakes; John C van Swieten; Armin Giese; Sigrun Roeber; Thomas Arzberger; Günter Höglinger
Journal:  Mov Disord       Date:  2020-03-03       Impact factor: 10.338

6.  The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.

Authors:  Luke A Massey; Hans R Jäger; Dominic C Paviour; Sean S O'Sullivan; Helen Ling; David R Williams; Constantinos Kallis; Janice Holton; Tamas Revesz; David J Burn; Tarek Yousry; Andrew J Lees; Nick C Fox; Caroline Micallef
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

7.  Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series.

Authors:  Carlos H Schenck; Bradley F Boeve; Mark W Mahowald
Journal:  Sleep Med       Date:  2013-01-22       Impact factor: 3.492

Review 8.  Clinicopathological review of pallidonigroluysian atrophy.

Authors:  Janice C Wong; Melissa J Armstrong; Anthony E Lang; Lili-Naz Hazrati
Journal:  Mov Disord       Date:  2012-10-31       Impact factor: 10.338

9.  Neuropathological criteria of anti-IgLON5-related tauopathy.

Authors:  Ellen Gelpi; Romana Höftberger; Francesc Graus; Helen Ling; Janice L Holton; Timothy Dawson; Mara Popovic; Janja Pretnar-Oblak; Birgit Högl; Erich Schmutzhard; Werner Poewe; Gerda Ricken; Joan Santamaria; Josep Dalmau; Herbert Budka; Tamas Revesz; Gabor G Kovacs
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

10.  Distribution patterns of tau pathology in progressive supranuclear palsy.

Authors:  Gabor G Kovacs; Milica Jecmenica Lukic; David J Irwin; Thomas Arzberger; Gesine Respondek; Edward B Lee; David Coughlin; Armin Giese; Murray Grossman; Carolin Kurz; Corey T McMillan; Ellen Gelpi; Yaroslau Compta; John C van Swieten; Laura Donker Laat; Claire Troakes; Safa Al-Sarraj; John L Robinson; Sigrun Roeber; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski; Günter U Höglinger
Journal:  Acta Neuropathol       Date:  2020-05-07       Impact factor: 17.088

View more
  1 in total

Review 1.  Pallidal degenerations and related disorders: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-08-07       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.